VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, announces ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Eduardo C. Alfonso, MD, and Steven H. Collis ...
The "Malabsorption Syndrome Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Malabsorption Syndrome was valued at US$3.5 Billion in ...
KENNESAW, GA / ACCESS Newswire / December 17, 2025 / Innovation in healthcare doesn't happen by accident, it happens by design. As regulations evolve, reimbursement models shift, and patient needs ...
The "Gastrointestinal Diagnostics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Gastrointestinal Diagnostics was valued at US$4.9 ...
The "Constipation Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Constipation Treatment was valued at US$19.5 Billion in 2024 ...
Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. (“PRISM”) to accelerate the discovery and ...
The "Drug Discount Cards Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Drug Discount Cards was valued at US$14.9 Billion in 2024 ...
RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world’s leading pharmaceutical manufacturers, today announced the ...
Ideagen achieved a market-leading score (3.0/3.0) for AI Operations in the Verdantix Green Quadrant for Quality Management ...
DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, today announced it has secured $3.5 million in funding from a prominent, family office. This significant investment solidifies the ...
Agreements Advance Biocerta’s Functional Precision Oncology Platform, Aiming to Deliver the Right Treatment, First Time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback